| Product NDC: | 10544-605 |
| Proprietary Name: | Ciprofloxacin |
| Non Proprietary Name: | ciprofloxacin |
| Active Ingredient(s): | 500 mg/1 & nbsp; ciprofloxacin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10544-605 |
| Labeler Name: | Blenheim Pharmacal, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075817 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100517 |
| Package NDC: | 10544-605-06 |
| Package Description: | 6 TABLET, FILM COATED in 1 BOTTLE (10544-605-06) |
| NDC Code | 10544-605-06 |
| Proprietary Name | Ciprofloxacin |
| Package Description | 6 TABLET, FILM COATED in 1 BOTTLE (10544-605-06) |
| Product NDC | 10544-605 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ciprofloxacin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20100517 |
| Marketing Category Name | ANDA |
| Labeler Name | Blenheim Pharmacal, Inc. |
| Substance Name | CIPROFLOXACIN |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |